GGrantIndex
← Search

HER2 PHOSPHORYLATION AND DIMERIZATION WITH EGFR PREDICT NEOADJUVANT HER2+ PCR FOR PERSONALIZED (ESCALATION OR DE-ESCALATION) BREAST CANCER THERAPY

$1,339,352FY2021Defense Health AgencyDOD

George Mason University, Fairfax VA

Investigators

View source on USAspending →
HER2 PHOSPHORYLATION AND DIMERIZATION WITH EGFR PREDICT NEOADJUVANT HER2+ PCR FOR PERSONALIZED (ESCALATION OR DE-ESCALATION) BREAST CANCER THERAPY · GrantIndex